发明公开
EP2938345A2 BENZAZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF
审中-公开
苯并氮杂五羟色胺5-HT 2C受体配体及其用途
- 专利标题： BENZAZEPINES AS SEROTONIN 5-HT2C RECEPTOR LIGANDS AND USES THEREOF
- 专利标题（中）： 苯并氮杂五羟色胺5-HT 2C受体配体及其用途
-
申请号： EP13864916.5申请日： 2013-12-23
-
公开(公告)号： EP2938345A2公开(公告)日： 2015-11-04
- 发明人: ROBARGE, Mike , HARRINGTON, John , GERRISH, David , MECOM, John
- 申请人： ABT Holding Company
- 申请人地址： 3201 Carnegie Avenue Cleveland, OH 44115 US
- 专利权人： ABT Holding Company
- 当前专利权人： ABT Holding Company
- 当前专利权人地址： 3201 Carnegie Avenue Cleveland, OH 44115 US
- 代理机构： Mullen, Lee Bryan
- 优先权： US201261745241P 20121221
- 国际公布： WO2014100815 20140626
- 主分类号： A61K31/55
- IPC分类号： A61K31/55
摘要：
The present invention generally relates to a series of compounds, to pharmaceutical compositions containing the compounds, and to use of the compounds and compositions as therapeutic agents. More specifically, compounds of the present invention are benzazepine compounds. These compounds are serotonin receptor (5-HT
2c ) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT
2c ) is desired (e.g. addiction, anxiety, depression, obesity, and others).
2c ) ligands and are useful for treating diseases, disorders, and conditions wherein modulation of the activity of serotonin receptors (5-HT
2c ) is desired (e.g. addiction, anxiety, depression, obesity, and others).
公开/授权文献
信息查询
